ACULAR^® ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. ACULAR^® ophthalmic solution is also indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction.

The recommended dose of ACULAR^® ophthalmic solution is one drop (0.25 mg) four times a day for relief of ocular itching due to seasonal allergic conjunctivitis.

For the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of ACULAR^® ophthalmic solution should be applied to the affected eye(s) four times daily beginning 24 hours after cataract surgery and continuing through the first 2 weeks of the postoperative period. ACULAR^® ophthalmic solution has been safely administered in conjunction with other ophthalmic medications such as antibiotics, beta blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.

ACULAR^® (ketorolac tromethamine ophthalmic solution) is supplied sterile in opaque white LDPE plastic bottles with white droppers with gray high impact polystyrene (HIPS) caps as follows: 3 mL in 6 mL bottle NDC 0023-2181-03, 5 mL in 10 mL bottle NDC 0023-2181-05, 10 mL in 10 mL bottle NDC 0023-2181-10.

Store at room temperature 15°C † 30°C (59°F- 86°F) with protection from light.

U.S. Pat.: 4,454,151; 5,110,493; and 5,414,011

©2002 Allergan, Irvine, CA 92612, U.S.A. Revised February 2002

ACULAR, a registered trademark of SYNTEX (U.S.A.) L.L.C., is manufactured and distributed by Allergan, Inc., under license from its developer, SYNTEX (U.S.A.) L.L.C., Palo Alto, CA, U.S.A. 8344X

Bookmark this page: